Editor's Picks   (Total records: loading...)
   Medical Diagnostics & Research    
 
        Insight Molecular Diagnostics Inc (IMDX) Q2 2025 Earnings Call Highlights: Strategic Advances Amid Revenue Challenges
        
  Insight Molecular Diagnostics Inc (IMDX) progresses towards FDA submission and product launch, despite facing revenue and expense hurdles.   Aug 12, 2025    



















